Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

Dr Thomas Hutson shares his experience with tivozanib in his practice and ways to counsel patients regarding treatment options in the third-line setting.

EP: 1.Treatment Options for Patients with Renal Cell Carcinoma (RCC)

EP: 2.Clinical Implications of the TIVO-3 Trial

EP: 3.Tivozanib: Adverse Event Profile and How Toxicities are Managed

Now Viewing

EP: 4.Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

EP: 5.Future Perspectives in Renal Cell Carcinoma (RCC)

Related Videos

Related Content

Advertisement

July 12th 2021

KCCure Patient Surveys Help Providers Understand Patients’ True Experiences During Treatment

Jamie Cesanek

The kidney cancer advocacy organization, KCCure, has been collecting survey data on patient experiences to help bridge the communication gap between providers and patients.

Related Content

Advertisement

July 12th 2021

KCCure Patient Surveys Help Providers Understand Patients’ True Experiences During Treatment

Jamie Cesanek

The kidney cancer advocacy organization, KCCure, has been collecting survey data on patient experiences to help bridge the communication gap between providers and patients.